Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Allison Mary Deal
Observed names:
A.M. Deal,
Allison Deal,
Allison M Deal,
Allison M. Deal,
Allison M. Deal,
Deal, Allison M,
Deal, Allison M.
show all 7
Institutions:
University of North Carolina at Chapel Hill,
UNC Lineberger Comprehensive Cancer Center
Observed institutions:
University of North Carolina at Chapel Hill,
University of North Carolina Hospitals,
UNC Lineberger Comprehensive Cancer Center
ORCID:
0000-0003-3526-3938
Observed ORCID:
0000-0003-3526-3938
OpenAlex ID:
A5111564375
Monitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model
2013
·
Christin E. Burd
, Jessica A. Sorrentino
, et al.
·
Cell
·
419
PDF
Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross‐sectional pharmacodynamic study based on peak and trough plasma levels
2013
·
E.M. Hawes
, A.M. Deal
, et al.
·
Journal of Thrombosis and Haemostasis
·
231
A reanalysis of nanoparticle tumor delivery using classical pharmacokinetic metrics
2020
·
Lauren S. L. Price
, Stephan T. Stern
, et al.
·
Science Advances
·
126
Performance of coagulation tests in patients on therapeutic doses of rivaroxaban
2014
·
Emily M. Hawes
, Allison M. Deal
, et al.
·
Thrombosis and Haemostasis
·
108
Profiling the relationship between tumor-associated macrophages and pharmacokinetics of liposomal agents in preclinical murine models
2016
·
Andrew T. Lucas
, Taylor F. White
, et al.
·
Nanomedicine Nanotechnology Biology and Medicine
·
17
Evaluation of the efficiency of tumor and tissue delivery of carrier-mediated agents (CMA) and small molecule (SM) agents in mice using a novel pharmacokinetic (PK) metric: relative distribution index over time (RDI-OT)
2014
·
Andrew J. Madden
, Sumit Rawal
, et al.
·
Journal of Nanoparticle Research
·
14
Methods for implementing and reporting the Patient‐Reported Outcomes version of the Common Terminology Criteria for Adverse Events to measure patient‐reported adverse events in cancer clinical trials
2025
·
Amylou C. Dueck
, Gita Thanarajasingam
, et al.
·
Cancer
·
12
PDF
Clinically relevant interaction between warfarin and scuppernongs, a quercetin containing muscadine grape: continued questions surrounding flavonoid-induced warfarin interactions
2014
·
Christopher J Woodward
, Zachariah M Deyo
, et al.
·
BMJ Case Reports
·
11
PDF
Associations Between Neurobehavioral Symptoms During Breast Cancer Chemotherapy and Patient‐Reported Cognitive Impairment 3 or More Years After Chemotherapy
2026
·
Jared D. Smith
, Alexis C. Wardell
, et al.
·
Psycho-Oncology
·
2
PDF
Comparison of patient-reported symptoms with multi-item patient-reported outcome measures of fatigue, anxiety, and depression in the clinical care of women undergoing chemotherapy for early breast cancer
2025
·
Kirsten A. Nyrop
, Allison M. Deal
, et al.
·
Quality of Life Research
·
2
Long‐Term Follow‐Up of Chemotherapy‐Associated Biological Aging in Women With Early Breast Cancer
2026
·
Hyman B. Muss
, Alexis C. Wardell
, et al.
·
Aging and Cancer
·
1
OA24.03 Cardiac Toxicity after Radiation for Stage III NSCLC: Pooled Analysis of Dose-Escalation Trials Delivering 70-90 Gy
2017
·
Kyle Wang
, Michael Eblan
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
Improvements in Health‐Related Quality of Life After Financial Navigation Among Cancer Survivors
2026
·
Thom, Bridgette
, Manning, Michelle L.
, et al.
·
UNC Libraries
Psychometric Evaluation of the PRO-CTCAE Average Composite Score: Reliability, Responsiveness, Known-Groups Validity, and Sensitivity to Group Differences
2026
·
Minji K. Lee
, Amylou C. Dueck
, et al.
·
Cancers
Quality of life and function in younger and older women treated for non-metastatic breast cancer: Three or more years post primary treatment
2026
·
Karie Turley
, Alexis C. Wardell
, et al.
·
Journal of Geriatric Oncology
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39)
2026
·
Allison M. Deal
, Yashasvini Sampathkumar
, et al.
·
JCO Oncology Practice
ProAE: an R package for graphical tools and standardized analysis of patient-reported outcomes and adverse events data
2025
·
Blake Langlais
, Brie Noble
, et al.
·
BMC Medical Informatics and Decision Making
A reanalysis of nanoparticle tumor delivery using classical pharmacokinetic metrics
2025
·
Deal, Allison M.
, Kabanov, Alexander V.
, et al.
·
Carolina Digital Repository (University of North Carolina at Chapel Hill)
Differences in COVID-19 preventive behaviors among Black and White cancer survivors in North Carolina
2025
·
Amanda Y. Kong
, Allison M. Deal
, et al.
·
Journal of Cancer Survivorship
PDF
Abstract P2-03-15: Identifying pre-habilitation targets for the mitigation of long-term side effects of chemotherapy in patients with early breast cancer
2025
·
Lyndsay Cooper
, Sasha Knowlton
, et al.
·
Clinical Cancer Research
Data from Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway
2023
·
Andrew J. Crowther
, Jennifer K. Ocasio
, et al.
Is the Relative Value of Operative Time Equal Across Surgical Specialties?
2019
·
Solomon Hayon
, Allison Deal
, et al.
·
Journal of the American College of Surgeons
Detection and quantitation of HPV in anogenital and oral tissues and fluids of HIV-positive individuals by real-time PCR
2019
·
Couch, Marion
, Webster-Cyriaque, Jennifer
, et al.
·
Carolina Digital Repository (University of North Carolina at Chapel Hill)
Feasibility and safety of cardiopulmonary exercise testing (CPET) in adults newly diagnosed with acute leukemia undergoing induction therapy.
2016
·
Ashley Leak Bryant
, Brett Phillips
, et al.
·
Journal of Clinical Oncology
Mp69-17 Evaluating the Timing of Surgical Complications Following Prostatectomy
2016
·
Jason Lomboy
, Matthew Macey
, et al.
·
The Journal of Urology
Show more works
View as search
Works count:
28
Citation count:
943
H-index:
8
I10-index:
8
Year
Topic
Type